Voya Investment Management LLC Sells 17,718 Shares of Agilent Technologies, Inc. $A

Voya Investment Management LLC reduced its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 15.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 98,991 shares of the medical research company’s stock after selling 17,718 shares during the period. Voya Investment Management LLC’s holdings in Agilent Technologies were worth $12,705,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Agilent Technologies by 1.8% during the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after purchasing an additional 589,219 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after buying an additional 1,273,994 shares in the last quarter. Geode Capital Management LLC increased its holdings in Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after buying an additional 115,183 shares during the last quarter. Generation Investment Management LLP grew its position in shares of Agilent Technologies by 15.9% in the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after acquiring an additional 792,304 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after purchasing an additional 604,124 shares during the last quarter.

Insider Buying and Selling

In other news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Trading Up 0.9%

Shares of A stock opened at $138.53 on Tuesday. The stock has a 50 day simple moving average of $145.45 and a 200 day simple moving average of $130.34. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The stock has a market cap of $39.27 billion, a P/E ratio of 30.31, a price-to-earnings-growth ratio of 3.98 and a beta of 1.27.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.01. The company had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is presently 21.66%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. The Goldman Sachs Group began coverage on Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Bank of America upped their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Finally, Evercore ISI raised their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $161.77.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.